Eurolife Healthcare launches innovative Intravenous IV products in the Indian Drug market.

Mumbai, June 29,2019: Eurolife Healthcare – Manufacturing and Distribution Company of Specialty Infusion & pharmaceuticals, today launched the high quality   Intravenous IV products name Discport and Lifeport in the Indian drug market. Positioned as Smart Intravenous Infusion, both products encompass the best of the latest technology that reduce the chances of any infections apart from ease of use.

Discport- Does not require any venting which ensures safety. It can be sterilized at 121* C & has lowest endotoxin levels. There is nil chance of any microbiological contamination and No DEHP Exposure.

Lifeport, known as Closed System Infusion (C I V Infusion), is a premium product with two ports one for the infusion delivery and another one for the extra medication. Lifeport does not require venting. It is self-collapsible bottle ensuring Zero wastage of expensive medication. No DEHP exposure, no drug incompatibility and no medication error.

These products are the replacement to the presently used PE bottles (FFS bottles) the new PP bottles have better quality with additional features and are available at affordable prices to the patients.

Mr. Sandeep Toshniwal, CEO of Eurolife Healthcare said, “We are dedicated to save lives of patients with our reliable and quality conscious manufacturing of premium healthcare products. We have more than 24 years of uninterrupted manufacturing expertise with state of art manufacturing facilities.”

Eurolife Healthcare aims to serve high quality innovation products to save lives.

Corporate Comm India(CCI Newswire)